TAL
AVDL

TIG Advisors LLC’s Avadel Pharmaceuticals AVDL Stock Holding History

TIG Advisors LLC’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,859,122
Closed -$83.2M – 108
2025
Q4 		$83.2M Buy
+3,859,122
New +$74.9M 3.85% 9

Other funds holding AVDL

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

TIG Advisors LLC's AVDL Position: Q1 2026 in Review

TIG Advisors LLC sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 3,859,122 shares — an estimated $83.2M sold.

TIG Advisors LLC first reported a position in AVDL in Q4 2025 and held it in 1 quarter. The position peaked at $83.2M in Q4 2025. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

  • TIG Advisors LLC reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • TIG Advisors LLC sold 3,859,122 Avadel Pharmaceuticals shares in Q1 2026, an estimated $83.2M.
  • TIG Advisors LLC first reported a position in Avadel Pharmaceuticals in Q4 2025 and held it in 1 quarter.
  • TIG Advisors LLC's Avadel Pharmaceuticals position peaked at $83.2M in Q4 2025.
  • 2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on TIG Advisors LLC's 13F filing for Q1 2026, filed 15 May 2026.